492 related articles for article (PubMed ID: 28409376)
1. Clinicopathologic features of early gastric carcinoma with lymphoid stroma and feasibility of endoscopic submucosal dissection.
Shin DH; Kim GH; Lee BE; Lee JW; Ha DW; Jeon HK; Baek DH; Song GA; Ahn SJ; Park DY
Surg Endosc; 2017 Oct; 31(10):4156-4164. PubMed ID: 28409376
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of endoscopic treatment and predictors of lymph node metastasis in early gastric cancer.
Chu YN; Yu YN; Jing X; Mao T; Chen YQ; Zhou XB; Song W; Zhao XZ; Tian ZB
World J Gastroenterol; 2019 Sep; 25(35):5344-5355. PubMed ID: 31558878
[TBL] [Abstract][Full Text] [Related]
3. Pre- and post-ESD discrepancies in clinicopathologic criteria in early gastric cancer: the NECA-Korea ESD for Early Gastric Cancer Prospective Study (N-Keep).
Kim JM; Sohn JH; Cho MY; Kim WH; Chang HK; Jung ES; Kook MC; Jin SY; Chae YS; Park YS; Kang MS; Kim H; Lee JH; Park DY; Kim KM; Kim H; Kim YW; Hwang SS; Seol SY; Jung HY; Lee NR; Park SH; You JH
Gastric Cancer; 2016 Oct; 19(4):1104-1113. PubMed ID: 26621523
[TBL] [Abstract][Full Text] [Related]
4. Clinical application of early gastric carcinoma with lymphoid stroma based on lymph node metastasis status.
Lim H; Lee IS; Lee JH; Park YS; Kang HJ; Na HK; Ahn JY; Kim DH; Choi KD; Song HJ; Lee GH; Jung HY; Kim JH; Kim BS; Yook JH; Kim BS
Gastric Cancer; 2017 Sep; 20(5):793-801. PubMed ID: 28205059
[TBL] [Abstract][Full Text] [Related]
5. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K
Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic features of gastric carcinoma with lymphoid stroma in early gastric cancer.
Huh CW; Jung DH; Kim H; Kim H; Youn YH; Park H; Kim JW; Choi SH; Noh SH; Kim JH
J Surg Oncol; 2016 Nov; 114(6):769-772. PubMed ID: 27450278
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of minimally invasive treatment for early gastric cancer in patients beyond the indications of endoscopic submucosal dissection.
Ko WJ; Kim YM; Yoo IK; Cho JY
Surg Endosc; 2018 Sep; 32(9):3798-3805. PubMed ID: 29464402
[TBL] [Abstract][Full Text] [Related]
8. Factors related to lymph node metastasis and the feasibility of endoscopic mucosal resection for treating poorly differentiated adenocarcinoma of the stomach.
Park YD; Chung YJ; Chung HY; Yu W; Bae HI; Jeon SW; Cho CM; Tak WY; Kweon YO
Endoscopy; 2008 Jan; 40(1):7-10. PubMed ID: 18210339
[TBL] [Abstract][Full Text] [Related]
9. Additional laparoscopic gastrectomy after noncurative endoscopic submucosal dissection for early gastric cancer: A single-center experience.
Tian YT; Ma FH; Wang GQ; Zhang YM; Dou LZ; Xie YB; Zhong YX; Chen YT; Xu Q; Zhao DB
World J Gastroenterol; 2019 Aug; 25(29):3996-4006. PubMed ID: 31413533
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for lymph node metastasis and long-term outcomes of patients with early gastric cancer after non-curative endoscopic submucosal dissection.
Kawata N; Kakushima N; Takizawa K; Tanaka M; Makuuchi R; Tokunaga M; Tanizawa Y; Bando E; Kawamura T; Sugino T; Kusafuka K; Shimoda T; Nakajima T; Terashima M; Ono H
Surg Endosc; 2017 Apr; 31(4):1607-1616. PubMed ID: 27495338
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus positivity, not mismatch repair-deficiency, is a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer.
Park JH; Kim EK; Kim YH; Kim JH; Bae YS; Lee YC; Cheong JH; Noh SH; Kim H
Gastric Cancer; 2016 Oct; 19(4):1041-1051. PubMed ID: 26573601
[TBL] [Abstract][Full Text] [Related]
12. Indication for endoscopic treatment based on the risk of lymph node metastasis in patients with undifferentiated early gastric cancer.
Liang XQ; Wang Z; Li HT; Ma G; Yu WW; Zhou HC; Liu HB
Asian J Surg; 2020 Oct; 43(10):973-977. PubMed ID: 31964584
[TBL] [Abstract][Full Text] [Related]
13. The Role of an Undifferentiated Component in Submucosal Invasion and Submucosal Invasion Depth After Endoscopic Submucosal Dissection for Early Gastric Cancer.
Miyahara K; Hatta W; Nakagawa M; Oyama T; Kawata N; Takahashi A; Yoshifuku Y; Hoteya S; Hirano M; Esaki M; Matsuda M; Ohnita K; Shimoda R; Yoshida M; Dohi O; Takada J; Tanaka K; Yamada S; Tsuji T; Ito H; Aoyagi H; Shimosegawa T
Digestion; 2018; 98(3):161-168. PubMed ID: 29870985
[TBL] [Abstract][Full Text] [Related]
14. Postoperative outcomes of gastric carcinoma with lymphoid stroma.
Iwasaki K; Suda T; Takano Y; Ohno Y; Yamada E; Okazaki N; Takahashi K; Watanabe T; Makuuchi Y; Ota Y; Osaka Y; Seshimo A; Katsumata K; Tsuchida A
World J Surg Oncol; 2020 May; 18(1):102. PubMed ID: 32438924
[TBL] [Abstract][Full Text] [Related]
15. Lymph node metastasis from intestinal-type early gastric cancer: experience in a single institution and reassessment of the extended criteria for endoscopic submucosal dissection.
Kang HJ; Kim DH; Jeon TY; Lee SH; Shin N; Chae SH; Kim GH; Song GA; Kim DH; Srivastava A; Park DY; Lauwers GY
Gastrointest Endosc; 2010 Sep; 72(3):508-15. PubMed ID: 20554277
[TBL] [Abstract][Full Text] [Related]
16. Lymph Node Metastasis in Mucosal Gastric Cancer: Reappraisal of Expanded Indication of Endoscopic Submucosal Dissection.
Oh SY; Lee KG; Suh YS; Kim MA; Kong SH; Lee HJ; Kim WH; Yang HK
Ann Surg; 2017 Jan; 265(1):137-142. PubMed ID: 28009738
[TBL] [Abstract][Full Text] [Related]
17. Very low risk of lymph node metastasis in Epstein-Barr virus-associated early gastric carcinoma with lymphoid stroma.
Cheng Y; Zhou X; Xu K; Huang J; Huang Q
BMC Gastroenterol; 2020 Aug; 20(1):273. PubMed ID: 32807085
[TBL] [Abstract][Full Text] [Related]
18. Optimal management for patients not meeting the inclusion criteria after endoscopic submucosal dissection for gastric cancer.
Toyokawa T; Ohira M; Tanaka H; Minamino H; Sakurai K; Nagami Y; Kubo N; Yamamoto A; Sano K; Muguruma K; Tominaga K; Nebiki H; Yamashita Y; Arakawa T; Hirakawa K
Surg Endosc; 2016 Jun; 30(6):2404-14. PubMed ID: 26463497
[TBL] [Abstract][Full Text] [Related]
19. Long-term oncological outcomes of submucosal manipulation during non-curative endoscopic submucosal dissection for submucosal invasive gastric cancer: a multicenter retrospective study in Japan.
Ito H; Gotoda T; Oyama T; Kawata N; Takahashi A; Yoshifuku Y; Hoteya S; Nakagawa M; Hatta W; Hirano M; Esaki M; Matsuda M; Ohnita K; Shimoda R; Yoshida M; Dohi O; Takada J; Tanaka K; Yamada S; Tsuji T; Hayashi Y; Nakaya N; Nakamura T; Shimosegawa T
Surg Endosc; 2018 Jan; 32(1):196-203. PubMed ID: 28639037
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus status is a promising biomarker for endoscopic resection in early gastric cancer: proposal of a novel therapeutic strategy.
Osumi H; Kawachi H; Yoshio T; Ida S; Yamamoto N; Horiuchi Y; Ishiyama A; Hirasawa T; Tsuchida T; Hiki N; Takeuchi K; Fujisaki J
J Gastroenterol; 2019 Sep; 54(9):774-783. PubMed ID: 30826866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
